|
PPRC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.460800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.068390E-01 |
| Normal-vs-Stage2 |
1.195380E-01 |
| Normal-vs-Stage3 |
9.657800E-01 |
| Normal-vs-Stage4 |
4.758000E-01 |
| Stage1-vs-Stage2 |
4.679000E-01 |
| Stage1-vs-Stage3 |
1.312150E-01 |
| Stage1-vs-Stage4 |
5.146300E-02 |
| Stage2-vs-Stage3 |
1.352440E-01 |
| Stage2-vs-Stage4 |
6.185600E-02 |
| Stage3-vs-Stage4 |
4.623200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.258000E-01 |
| Normal-vs-AfricanAmerican |
2.013600E-01 |
| Normal-vs-Asian |
7.161000E-01 |
| Caucasian-vs-AfricanAmerican |
7.296800E-01 |
| Caucasian-vs-Asian |
8.758200E-01 |
| AfricanAmerican-vs-Asian |
7.819600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.852100E-02 |
| Normal-vs-Female |
7.484200E-01 |
| Male-vs-Female |
2.536700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.674360E-01 |
| Normal-vs-Extreme_Weight |
1.677770E-01 |
| Normal-vs-Obese |
7.160800E-01 |
| Normal-vs-Extreme_Obese |
1.378370E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.206600E-01 |
| Normal_Weight-vs-Obese |
2.450600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.434000E-01 |
| Extreme_Weight-vs-Obese |
2.202600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.488200E-01 |
| Obese-vs-Extreme_Obese |
1.952950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.956200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.490400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.691700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.699700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.137300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.950250E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.079170E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.571700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.870500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.853970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.560840E-01 |
| Normal-VS-Type2 PRCC |
1.266090E-02 |
| Normal-VS-KIRP CIMP |
4.703700E-03 |
| Normal-VS-Unclassified PRCC |
5.414800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.849700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.3794999999559E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
5.221400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.90320000554345E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
6.148500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.033000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.547770E-02 |
| Normal-vs-N1 |
1.179400E-01 |
| Normal-vs-N2 |
3.968400E-01 |
| N0-vs-N1 |
1.115710E-03 |
| N0-vs-N2 |
4.424100E-03 |
| N1-vs-N2 |
9.662000E-01 |
|
|
